JY
PCVX icon

Jeff Yass’s Vaxcyte PCVX Stock Holding History

Jeff Yass’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$651K Sell
11,206
-35,867
-76% -$1.95M ﹤0.01% 9290
2026
Q1 		$2.74M Buy
47,073
+12,957
+38% +$703K ﹤0.01% 5463
2025
Q4 		$1.57M Sell
34,116
-84,618
-71% -$3.78M ﹤0.01% 6132
2025
Q3 		$4.28M Sell
118,734
-34,118
-22% -$1.13M ﹤0.01% 4345
2025
Q2 		$4.97M Sell
152,852
-165,486
-52% -$5.42M ﹤0.01% 3981
2025
Q1 		$12M Buy
318,338
+192,942
+154% +$15.4M ﹤0.01% 2294
2024
Q4 		$10.3M Buy
125,396
+80,926
+182% +$8.04M ﹤0.01% 2631
2024
Q3 		$5.08M Buy
44,470
+20,343
+84% +$1.83M ﹤0.01% 3563
2024
Q2 		$1.82M Sell
24,127
-19,684
-45% -$1.34M ﹤0.01% 5275
2024
Q1 		$2.99M Buy
43,811
+13,113
+43% +$908K ﹤0.01% 4522
2023
Q4 		$1.93M Buy
30,698
+8,993
+41% +$467K ﹤0.01% 5436
2023
Q3 		$1.11M Sell
21,705
-5,684
-21% -$280K ﹤0.01% 6409
2023
Q2 		$1.37M Sell
27,389
-63,216
-70% -$3M ﹤0.01% 5971
2023
Q1 		$3.4M Buy
90,605
+74,647
+468% +$3.17M ﹤0.01% 4074
2022
Q4 		$765K Sell
15,958
-27,498
-63% -$1.08M ﹤0.01% 6767
2022
Q3 		$1.04M Sell
43,456
-19,375
-31% -$491K ﹤0.01% 6531
2022
Q2 		$1.37M Buy
62,831
+47,071
+299% +$1.09M ﹤0.01% 5770
2022
Q1 		$381K Sell
15,760
-4,384
-22% -$95.8K ﹤0.01% 9669
2021
Q4 		$479K Buy
20,144
+5,378
+36% +$125K ﹤0.01% 9324
2021
Q3 		$375K Sell
14,766
-4,170
-22% -$101K ﹤0.01% 10080
2021
Q2 		$426K Buy
+18,936
New +$388K ﹤0.01% 9968

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Jeff Yass's PCVX Position: Q2 2026 in Review

Jeff Yass reduced its Vaxcyte (PCVX) stake by 76% in Q2 2026, selling an estimated $1.95M and leaving 11,206 shares worth $651K. The position accounts for ﹤0.01% of the portfolio, ranked #9290.

Jeff Yass first reported a position in PCVX in Q2 2021 and has held it in 21 quarters since. The position peaked at $12M in Q1 2025. 330 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Jeff Yass held 11,206 shares of Vaxcyte worth $651K as of Q2 2026.
  • Jeff Yass sold 35,867 Vaxcyte shares in Q2 2026, an estimated $1.95M.
  • Vaxcyte made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #9290 holding.
  • Jeff Yass first reported a position in Vaxcyte in Q2 2021 and has held it in 21 quarters since.
  • Jeff Yass's Vaxcyte position peaked at $12M in Q1 2025.
  • 330 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.